Skip to main content
Cureus logoLink to Cureus
. 2022 Dec 27;14(12):e33019. doi: 10.7759/cureus.33019

Delayed, Progressive Multivessel Occlusion After Resection of a Recurrent Glioma

Onur Tanglay 1, Nicholas B Dadario 2, Isabella M Young 3, Jacky T Yeung 4, Charles Teo 1, Michael E Sughrue 1,
Editors: Alexander Muacevic, John R Adler
PMCID: PMC9879796  PMID: 36721529

Abstract

Glioblastoma multiforme (GBM) is one of the most common primary brain tumors with an aggressive natural history consistent with a median survival of less than two years. Most clinical research has primarily focused on improving overall survival through aggressive cytoreductive surgery and adjuvant radiochemotherapy. However, far less clinical guidance has been given for unexpected instances of neurologic decline following safe glioma resection in the setting of vascular etiology. Here, we report a 50-year-old man who presented to our clinic with a seizure. His preoperative magnetic resonance imaging (MRI) demonstrated a left hippocampal glioblastoma. Ten months following total resection, the patient presented again with rapid loss of vision and hemorrhagic papilledema. An MRI demonstrated a recurrence of his glioma, which was partially resected with no complications. Eight days after surgery, the patient suddenly became unresponsive and imaging revealed moderate blood in the resection cavity, which was evacuated in the operating room. Follow-up scans showed a posterior cerebral artery infarction, and two days later, a middle cerebral artery infarction, upon which care was withdrawn. We do not propose a mechanism by which this delayed ischemia occurred, especially as the middle cerebral artery was not damaged during surgery, however, we note that delayed ischemia may be one mechanism of damage following glioma resection, which should be studied further to improve patient outcomes.

Keywords: glioblastoma, resection, glioma, ischemia, complication

Introduction

It is well-established that glioblastoma confers a hypercoagulable state in patients [1-4]. The high rate of deep venous thrombosis is one manifestation of this phenomenon [5]. It is also well-known that ischemic injury can occur following the resection of gliomas [6-8]. While there is nearly always diffusion restriction around the edge of a resection cavity [9], it is far more substantial when, in some cases, the diffusion restriction extends along with vascular territories well outside the field of resection, suggesting loss of arterial vessel patency [10,11]. Most commonly, this is the result of injury to a blood vessel during surgery [10].

While it is known that the events following brain trauma involve a complex set of compensatory, and in some cases, detrimental molecular and cellular cascades in response to the injury [12], far fewer studies have been directed toward the events following resection of gliomas, which differ in the focality of the injury and the presence of tumor tissue in the neighboring brain. The case presented here provides one example of a potentially unique mechanism, namely, the role of delayed vascular ischemia, which may occur in some patients and therefore represents an important area of future study to optimize postoperative outcomes.

Case presentation

The patient was a 50-year-old man who presented with a seizure and was subsequently found to have a left hippocampal glioblastoma. The mass was resected in total, and the patient was clinically stable following surgery. Pre- and postoperative imaging can be seen in Figure 1. His follow-up treatment plan included standard adjuvant fractionated radiotherapy and temozolomide per the Stupp protocol [13].

Figure 1. Preoperative and postoperative neuroimaging.

Figure 1

Preoperative (A) and postoperative (B) axial and coronal gadolinium-enhanced T1 and T2-weighted MR images demonstrating a left hippocampal glioma and the effects of a subsequent total resection.

He remained well for approximately 10 months until he experienced a rapid loss of his vision over two days without prior warning or previous visual complaints. The patient was examined and found to have hemorrhagic papilledema. His MRI also demonstrated a recurrent tumor around the edges of the previous resection cavity (Figure 2A). The best hypothesis for the rapid decline in his neurologic status was that the tumor was causing increased intracranial pressure. The decision was made to take the patient to the operating room and remove his recurrent tumor. During the procedure, the patient’s brain was not markedly swollen, and we were able to remove all but a thin layer of tumor in the medial temporal lobe (Figure 2B). We did not see or cauterize any vessels medial to the tentorial incisura. The postoperative diffusion-weighted MRI scan did not demonstrate any evidence of ischemic stroke (Figure 2C).

Figure 2. Neuroimaging of delayed ischemia.

Figure 2

Preoperative (A) and postoperative (B) axial gadolinium-enhanced T1-weighted MR images showing a recurrence of the temporal glioma around the edges of the previous resection cavity and partial resection with a thin layer of tumor remaining in the medial temporal lobe. Postoperative DWI (C) shows no evidence of ischemia. Eight days following surgery, DWI shows acute blood in the resection cavity while CT imaging shows a dense PCA (D). Two days following this scan, imaging revealed a large MCA infarction (E).

DWI: diffusion-weighted imaging; PCA: posterior cerebral artery; MCA: middle cerebral artery

The patient did well initially for eight days after the surgery. He was walking in the hallways and had a normal neurologic exam save for his loss of vision, which was unchanged following surgery. The patient then abruptly became unresponsive while recovering in a rehabilitation facility and was found to have a moderate amount of blood in the resection cavity. Even though it was unclear how a relatively small amount of blood could cause his significant decline, it was decided to take him to the operating room, and we performed an emergency clot evacuation. During that surgery, no active site of bleeding was noted, and no vessels were cauterized. The patient’s follow-up scans showed a left posterior cerebral artery (PCA) infarction, which had developed in the intervening period from the initial postoperative scan (Figure 2D). A monitor placed during the clot evacuation surgery demonstrated no increased intracranial pressure in the immediate postoperative period. Two days later, repeat imaging demonstrated interval development of a dense middle cerebral artery (MCA) stroke (Figure 2E). Subsequently, the patient’s intracranial pressure could not be controlled, and following discussions with the family, care was withdrawn.

Postmortem examination demonstrated only the post-surgical changes and ischemic stroke described. There were no signs of infection during the postoperative period. Cerebrospinal fluid sent during the perioperative period showed no signs of infection following the intracranial hemorrhage, PCA stroke, or MCA stroke.

Discussion

In this case, we report an example of a patient who underwent an uncomplicated resection of a recurrent temporal glioma in the setting of hemorrhagic papilledema. The patient was initially stable following surgery but proceeded to develop an intracranial hemorrhage into his resection cavity as well as a PCA stroke approximately one week following surgery, which were not present on immediate postoperative scans. The patient went on to expire from an interval MCA stroke.

In cases such as this, it is often difficult to find a satisfactory explanation, yet we may speculate on the underlying cause. One possibility is that the patient developed fulminant, progressive deterioration, with vasculopathy playing a central role. While the hemorrhagic papilledema suggested that the patient had increased intracranial pressure, we have no evidence that his intracranial pressure was ever elevated at any point in his care. Therefore, vascular etiology may be more likely. Indeed, hemorrhagic papilledema has been reported in several cases, including chronic myeloid leukemia, paroxysmal nocturnal hemoglobinuria, iron deficiency anemia, and subarachnoid hemorrhage [14-22]. Given the sequential occlusion of two vessels that were not manipulated during the patient’s second tumor surgery, this raises the possibility of hypercoagulable state-related vessel occlusion or other vasculopathies [23-27].

Most neurologic decline following glioma surgery is attributed to brain swelling [28]. However, this case provides a dramatic example of the possible role of other mechanisms in neurologic decline following glioma resection. The idea that hypercoagulability [29], vasospasm [30], or venous congestion [31] could be exacerbating postoperative ischemia raises important questions about where we might intervene to improve patient outcomes, which require further study to answer.

Conclusions

This report presents a rare case of an uncomplicated recurrent GBM resection, which resulted in a delayed intracranial hemorrhage into the resection cavity and then a subsequent PCA and MCA stroke one week postoperatively. Further study is necessary to better understand the mechanisms of brain injury following uncomplicated glioma resection, which may result in immediate or delayed postoperative ischemia in order to optimize opportunities for vascular intervention in the perioperative period. In particular, delayed ischemia may occur after glioma resection without obvious iatrogenic injury and therefore demonstrates an unclear mechanism and an important possibility that neurosurgeons should consider in glioma surgery moving forward.

The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.

The authors have declared that no competing interests exist.

Human Ethics

Consent was obtained or waived by all participants in this study

References

  • 1.Anticoagulation of malignant glioma patients in the era of novel antiangiogenic agents. Perry JR. Curr Opin Neurol. 2010;23:592–596. doi: 10.1097/WCO.0b013e32833feb73. [DOI] [PubMed] [Google Scholar]
  • 2.Recurrent venous thromboembolism in glioblastoma. Edwin NC, Khoury MN, Sohal D, McCrae KR, Ahluwalia MS, Khorana AA. https://doi.org/10.1016/j.thromres.2015.11.027. Thromb Res. 2016;137:184–188. doi: 10.1016/j.thromres.2015.11.027. [DOI] [PubMed] [Google Scholar]
  • 3.The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence-based review. Marras LC, Geerts WH, Perry JR. Cancer. 2000;89:640–646. doi: 10.1002/1097-0142(20000801)89:3<640::aid-cncr20>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  • 4.Thromboembolic disease in patients with high-grade glioma. Perry JR. Neuro Oncol. 2012;14 Suppl 4:0–80. doi: 10.1093/neuonc/nos197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Comorbid conditions associated with glioblastoma. Fisher JL, Palmisano S, Schwartzbaum JA, Svensson T, Lönn S. J Neurooncol. 2014;116:585–591. doi: 10.1007/s11060-013-1341-x. [DOI] [PubMed] [Google Scholar]
  • 6.Ischemic stroke in patients with gliomas at The University of Texas-M.D. Anderson Cancer Center. Kamiya-Matsuoka C, Cachia D, Yust-Katz S, Rodriguez YA, Garciarena P, Rodarte EM, Tremont-Lukats IW. J Neurooncol. 2015;125:143–148. doi: 10.1007/s11060-015-1880-4. [DOI] [PubMed] [Google Scholar]
  • 7.Ischemic stroke in patients with primary brain tumors. Kreisl TN, Toothaker T, Karimi S, DeAngelis LM. Neurology. 2008;70:2314–2320. doi: 10.1212/01.wnl.0000314648.82924.6f. [DOI] [PubMed] [Google Scholar]
  • 8.Risk of ischemia in glioma surgery: comparison of first and repeat procedures. Dützmann S, Geßler F, Bink A, Quick J, Franz K, Seifert V, Senft C. J Neurooncol. 2012;107:599–607. doi: 10.1007/s11060-011-0784-1. [DOI] [PubMed] [Google Scholar]
  • 9.Clinical and radiographic features of peritumoral infarction following resection of glioblastoma. Ulmer S, Braga TA, Barker FG 2nd, Lev MH, Gonzalez RG, Henson JW. Neurology. 2006;67:1668–1670. doi: 10.1212/01.wnl.0000242894.21705.3c. [DOI] [PubMed] [Google Scholar]
  • 10.Postoperative ischemic changes following resection of newly diagnosed and recurrent gliomas and their clinical relevance. Gempt J, Förschler A, Buchmann N, et al. J Neurosurg. 2013;118:801–808. doi: 10.3171/2012.12.JNS12125. [DOI] [PubMed] [Google Scholar]
  • 11.Serial diffusion-weighted magnetic resonance imaging in cases of glioma: distinguishing tumor recurrence from postresection injury. Smith JS, Cha S, Mayo MC, et al. J Neurosurg. 2005;103:428–438. doi: 10.3171/jns.2005.103.3.0428. [DOI] [PubMed] [Google Scholar]
  • 12.Cellular and molecular mechanisms of injury and spontaneous recovery. McGinn MJ, Povlishock JT. Handb Clin Neurol. 2015;127:67–87. doi: 10.1016/B978-0-444-52892-6.00005-2. [DOI] [PubMed] [Google Scholar]
  • 13.Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. Stupp R, Mason WP, van den Bent MJ, et al. N Engl J Med. 2005;352:987–996. doi: 10.1056/NEJMoa043330. [DOI] [PubMed] [Google Scholar]
  • 14.Bilateral optic disc swelling, vitreous haemorrhage and Roth’s spots in chronic myeloid leukemia [Article in German] Rothenbuehler SP, Palmowski-Wolfe AM, Passweg JR, Hollbach N. Klin Monbl Augenheilkd. 2015;232:564–565. doi: 10.1055/s-0035-1545806. [DOI] [PubMed] [Google Scholar]
  • 15.Papilledema secondary to Burkitt lymphoma. Santos-Bueso E, Asorey-García A, Gegúndez-Fernández JA, Vinuesa-Silva JM, García-Sánchez J. Arch Soc Esp Oftalmol. 2015;90:396–397. doi: 10.1016/j.oftal.2013.12.007. [DOI] [PubMed] [Google Scholar]
  • 16.Bilateral papilledema with retinal hemorrhages in association with cerebral venous sinus thrombosis and paroxysmal nocturnal hemoglobinuria. Hauser D, Barzilai N, Zalish M, Oliver M, Pollack A. Am J Ophthalmol. 1996;122:592–593. doi: 10.1016/s0002-9394(14)72130-0. [DOI] [PubMed] [Google Scholar]
  • 17.Anemia and papilledema. Biousse V, Rucker JC, Vignal C, Crassard I, Katz BJ, Newman NJ. Am J Ophthalmol. 2003;135:437–446. doi: 10.1016/s0002-9394(02)02062-7. [DOI] [PubMed] [Google Scholar]
  • 18.Subarachnoid hemorrhage: intraocular symptoms and their pathogenesis. Manschot W. Am J Ophthalmol. 1954;38:501–505. [PubMed] [Google Scholar]
  • 19.Papilledema with unusual ocular hemorrhages. Keane JR. Arch Ophthalmol. 1981;99:262–263. doi: 10.1001/archopht.1981.03930010264008. [DOI] [PubMed] [Google Scholar]
  • 20.Subretinal neovascularization and papilledema associated with pseudotumor cerebri. Jamison RR. Am J Ophthalmol. 1978;85:78–81. doi: 10.1016/s0002-9394(14)76669-3. [DOI] [PubMed] [Google Scholar]
  • 21.Intravitreal hemorrhage associated with rapid increase in intracranial pressure (Terson's syndrome) Khan SG, Frenkel M. Am J Ophthalmol. 1975;80:37–43. doi: 10.1016/0002-9394(75)90865-x. [DOI] [PubMed] [Google Scholar]
  • 22.Mechanisms of visual loss in papilledema. Schirmer CM, Hedges TR 3rd. Neurosurg Focus. 2007;23:0. doi: 10.3171/FOC-07/11/E5. [DOI] [PubMed] [Google Scholar]
  • 23.Symposium on the diagnosis and treatment of intravascular coagulation-fibrinolysis (ICF) syndrome, with special emphasis on this syndrome in patients with cancer. Introduction. Bowie EJ, Owen CA Jr. https://pubmed.ncbi.nlm.nih.gov/4416013/ Mayo Clin Proc. 1974;49:635. [PubMed] [Google Scholar]
  • 24.Blood coagulation studies in patients with cancer. Sun N, Bowie E, Kazmier F, Elveback L, Owen Jr CA. Mayo Clin Proc. 1974 [PubMed] [Google Scholar]
  • 25.Abnormalities of blood coagulation in patients with cancer. Fibrinopeptide A generation and tumor growth. Rickles FR, Edwards RL, Barb C, Cronlund M. Cancer. 1983;51:301–307. doi: 10.1002/1097-0142(19830115)51:2<301::aid-cncr2820510223>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  • 26.Hemostatic changes in patients with brain tumors. Thoron L, Arbit E. J Neurooncol. 1994;22:87–100. doi: 10.1007/BF01052885. [DOI] [PubMed] [Google Scholar]
  • 27.Thromboembolic complications associated with brain tumors. Sawaya RE, Ligon BL. J Neurooncol. 1994;22:173–181. doi: 10.1007/BF01052892. [DOI] [PubMed] [Google Scholar]
  • 28.Complications of glioma surgery. Jackson C, Westphal M, Quiñones-Hinojosa A. Handb Clin Neurol. 2016;134:201–218. doi: 10.1016/B978-0-12-802997-8.00012-8. [DOI] [PubMed] [Google Scholar]
  • 29.Brain neoplasms and coagulation. Magnus N, D'Asti E, Garnier D, Meehan B, Rak J. Semin Thromb Hemost. 2013;39:881–895. doi: 10.1055/s-0033-1357483. [DOI] [PubMed] [Google Scholar]
  • 30.Cerebral vasospasm detection by TCD after supratentorial brain tumours surgery. el Hendawy M, Wronski J, Juniewicz H, Szarek W, Wojda J. https://pubmed.ncbi.nlm.nih.gov/11452846/ Neurol Neurochir Pol. 2000;34:114–123. [PubMed] [Google Scholar]
  • 31.Correlation between the efferent venous drainage of the tumor and peritumoral edema in intracranial meningiomas: superselective angiographic analysis of 25 cases. Tanaka M, Imhof HG, Schucknecht B, Kollias S, Yonekawa Y, Valavanis A. J Neurosurg. 2006;104:382–388. doi: 10.3171/jns.2006.104.3.382. [DOI] [PubMed] [Google Scholar]

Articles from Cureus are provided here courtesy of Cureus Inc.

RESOURCES